statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report)'s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.92 and...

Sensus Healthcare (NASDAQ:SRTS) Share Price Passes Below Fifty Day Moving Average of $3.92

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 65,800 shares, an...

Short Interest in Sensus Healthcare, Inc. (NASDAQ:SRTS) Expands By 166.4%

Management will discuss its new Fair Deal Agreement for its SRT-100 Vision IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th BOCA RATON, Fla., March 14, 2024...

Sensus Healthcare to Participate in the 36th Annual Roth Conference

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company's booth generated a record-high...

Sensus Healthcare Launches  Fair Deal Agreement  for its SRT-100 Vision  at the American Academy of Dermatology Annual Meeting

BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy...

SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555

Maxim Group analyst Anthony Vendetti has maintained their bullish stance on SRTS stock, giving a Buy rating yesterday. Anthony Vendetti has given h...

Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript...

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditionsIntroduces recurring revenue model for the SRT-100 Vision (IG-SRT...

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision  System (IG-SRT) Capabilities

Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammatory diseases BOCA RATON, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE...

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Volume	47,636.00
52-Wk High	$5.38
52-Wk Low	$1.79

SRTS Sensus Healthcare Inc

About

Feed

News

Earnings

Fundamentals